Biotech

All Articles

Praxis epilepsy medicine lessens seizures in phase 2 trial

.Praxis Accuracy Medicines has racked up yet another midphase gain in epilepsy this year, with its s...

Three officers resign as Dyne articles combined data for DMD prospect

.After leaving a professional hold a number of years back, Dyne Therapy has shown new period 1/2 inf...

Arrowhead fires off phase 3 records in unusual metabolic ailment in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its own hand ahead of a possible face-off along with I...

Pfizer, Valneva present lyme ailment try efficient for 2nd booster

.Pfizer and also Valneva may possess regarding 2 more years to stand by just before they create the ...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Let's study a conversation with Ayla Ellison, Tough Biotech Editor-in-Chief and also Michelle Benz ...

New records show how Bayer's asundexian stopped working to avoid movements

.Bayer suspended the phase 3 trial for its element XIa inhibitor asundexian behind time in 2015 afte...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its various sclerosis (MS) med tolebrutinib to the FDA, execs have...

Galapagos' stockpile as fund reveals intent to mold its own advancement

.Galapagos is happening under added pressure coming from clients. Having actually developed a 9.9% r...

Cell- focused Sana gathers initial CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings ...

Allist pays Jacobio $21M, landing task in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has actually acquired on its own a starring character in China's KR...